Literature DB >> 27153031

Drug Repurposing for Terminal-Stage Cancer Patients.

Boris Cvek1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27153031      PMCID： PMC4880249          DOI： 10.2105/AJPH.2016.303129

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  4 in total

1.  The Myth Regarding the High Cost of End-of-Life Care.

Authors:  Melissa D Aldridge; Amy S Kelley
Journal:  Am J Public Health       Date:  2015-10-15       Impact factor: 9.308

2.  Drugs on demand.

Authors: 
Journal:  Nature       Date:  2015-11-26       Impact factor: 49.962

3.  Nonprofit drugs as the salvation of the world's healthcare systems: the case of Antabuse (disulfiram).

Authors:  Boris Cvek
Journal:  Drug Discov Today       Date:  2011-12-16       Impact factor: 7.851

4.  A phase IIb trial assessing the addition of disulfiram to chemotherapy for the treatment of metastatic non-small cell lung cancer.

Authors:  Hovav Nechushtan; Yousef Hamamreh; Salim Nidal; Maya Gotfried; Amichai Baron; Yossi Israeli Shalev; Benjjamin Nisman; Tamar Peretz; Nili Peylan-Ramu
Journal:  Oncologist       Date:  2015-03-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.